Mitsubishi Chemical sells pharmaceuticals subsidiary to Bain in $3.36 billion deal

Mitsubishi Chemical

07/02/2025 07:11

TOKYO, Feb 7 (Reuters) - Japan's Mitsubishi Chemical
 4188.T  said on Friday it will sell pharmaceutical subsidiary
Tanabe Mitsubishi Pharma to U.S. private equity firm Bain
Capital in a deal worth 510 billion yen ($3.36 billion) as it
seeks to streamline its portfolio.
    Private equity-led buyouts are booming in Japan as Japanese
firms increasingly carve out non-core businesses in an effort to
raise corporate and shareholder value.
    ($1 = 151.8400 yen)

 (Reporting by Anton Bridge; Editing by Christopher Cushing)
 ((Anton.Bridge@thomsonreuters.com;))